Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study - PubMed (original) (raw)
Multicenter Study
. 2008 May 6;51(18):1775-83.
doi: 10.1016/j.jacc.2007.12.048.
Affiliations
- PMID: 18452784
- DOI: 10.1016/j.jacc.2007.12.048
Free article
Multicenter Study
Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study
Hossein Bahrami et al. J Am Coll Cardiol. 2008.
Free article
Abstract
Objectives: The objectives of this study were to determine the associations of the metabolic syndrome, inflammatory markers, and insulin resistance with incident congestive heart failure (CHF), beyond established risk factors, and to examine whether these risk factors may provide the link between obesity and CHF.
Background: Recently, increasing interest has emerged on the potential role of novel risk factors such as systemic inflammation, insulin resistance, and albuminuria in the pathophysiology of CHF and their relationship with obesity.
Methods: The MESA (Multi-Ethnic Study of Atherosclerosis) study is a community-based multicenter cohort study of 6,814 participants (age 45 to 84 years, 3,601 women) of 4 ethnicities: Caucasians, African Americans, Hispanics, and Chinese Americans. Participants were recruited between 2000 and 2002 from 6 U.S. communities. Median follow-up time was 4 years. Participants with history of symptomatic cardiovascular disease were excluded. Cox proportional hazards models were used to analyze the associations of the metabolic syndrome, inflammatory markers, insulin resistance, and albuminuria with incident CHF, independent of established risk factors (age, gender, hypertension, diabetes mellitus, left ventricular hypertrophy, obesity, serum total cholesterol, and smoking), an interim myocardial infarction, and baseline magnetic resonance imaging parameters of left ventricular structure and function.
Results: A total of 79 participants developed CHF during follow-up, and 26 participants (32.9%) had a myocardial infarction prior to CHF and 65% of the cases had CHF with preserved function (left ventricular ejection fraction >or=40%). In multivariable analyses, serum interleukin-6 (hazard ratio [HR] for 1 standard deviation 1.50, 95% confidence interval [CI] 1.10 to 2.03) or C-reactive protein (HR for 1 standard deviation 1.38; 95% CI 1.01 to 1.86) and macroalbuminuria (HR 4.31, 95% CI 1.58 to 11.76) were predictors of CHF, independent of obesity and the other established risk factors. Although obesity was significantly associated with incident CHF, this association was no longer significant after adding inflammatory markers (interleukin-6 or C-reactive protein) to the model.
Conclusions: Inflammatory markers and albuminuria are independent predictors of CHF. The association of obesity and CHF may be related to pathophysiologic pathways associated with inflammation.
Similar articles
- Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis.
Bahrami H, Kronmal R, Bluemke DA, Olson J, Shea S, Liu K, Burke GL, Lima JA. Bahrami H, et al. Arch Intern Med. 2008 Oct 27;168(19):2138-45. doi: 10.1001/archinte.168.19.2138. Arch Intern Med. 2008. PMID: 18955644 Free PMC article. - Insulin resistance and risk of congestive heart failure.
Ingelsson E, Sundström J, Arnlöv J, Zethelius B, Lind L. Ingelsson E, et al. JAMA. 2005 Jul 20;294(3):334-41. doi: 10.1001/jama.294.3.334. JAMA. 2005. PMID: 16030278 - Metabolic syndrome, inflammation, and incident heart failure in the elderly: the cardiovascular health study.
Suzuki T, Katz R, Jenny NS, Zakai NA, LeWinter MM, Barzilay JI, Cushman M. Suzuki T, et al. Circ Heart Fail. 2008 Nov;1(4):242-8. doi: 10.1161/CIRCHEARTFAILURE.108.785485. Epub 2008 Sep 23. Circ Heart Fail. 2008. PMID: 19808298 Free PMC article. - Interrelationships between inflammation, C-reactive protein, and insulin resistance.
Ndumele CE, Pradhan AD, Ridker PM. Ndumele CE, et al. J Cardiometab Syndr. 2006 Summer;1(3):190-6. doi: 10.1111/j.1559-4564.2006.05538.x. J Cardiometab Syndr. 2006. PMID: 17679826 Review. - Prevalence, incidence and risk factors of chronic heart failure in the type 2 diabetic population: systematic review.
Zhou L, Deng W, Zhou L, Fang P, He D, Zhang W, Liu K, Hu R. Zhou L, et al. Curr Diabetes Rev. 2009 Aug;5(3):171-84. doi: 10.2174/157339909788920938. Curr Diabetes Rev. 2009. PMID: 19689252 Review.
Cited by
- Prognostic Implications of Insulin Resistance in Heart Failure in Japan.
Iwasaki K, Nakamura K, Akagi S, Takaya Y, Toda H, Miyoshi T, Yuasa S. Iwasaki K, et al. Nutrients. 2024 Jun 14;16(12):1888. doi: 10.3390/nu16121888. Nutrients. 2024. PMID: 38931242 Free PMC article. - Global epidemiology of heart failure.
Khan MS, Shahid I, Bennis A, Rakisheva A, Metra M, Butler J. Khan MS, et al. Nat Rev Cardiol. 2024 Oct;21(10):717-734. doi: 10.1038/s41569-024-01046-6. Epub 2024 Jun 26. Nat Rev Cardiol. 2024. PMID: 38926611 Review. - Predictive Effect of Alternative Insulin Resistance Indexes on Adverse Cardiovascular Events in Patients with Metabolic Syndrome with Heart Failure.
Xie Q, Liu C, Liu F, Zhang X, Zhang Z, An X, Yang Y, Li X. Xie Q, et al. Diabetes Metab Syndr Obes. 2024 Jun 10;17:2347-2356. doi: 10.2147/DMSO.S457598. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38881693 Free PMC article. - Impact of Sex and Diabetes in Patients with Heart Failure.
Álvarez-Zaballos S, Martínez-Sellés M. Álvarez-Zaballos S, et al. Curr Heart Fail Rep. 2024 Aug;21(4):389-395. doi: 10.1007/s11897-024-00666-w. Epub 2024 May 3. Curr Heart Fail Rep. 2024. PMID: 38698294 Review. - Associations between non-insulin-based insulin resistance indices and heart failure prevalence in overweight/obesity adults without diabetes mellitus: evidence from the NHANES 2001-2018.
Cui DY, Zhang C, Chen Y, Qian GZ, Zheng WX, Zhang ZH, Zhang Y, Zhu P. Cui DY, et al. Lipids Health Dis. 2024 Apr 27;23(1):123. doi: 10.1186/s12944-024-02114-z. Lipids Health Dis. 2024. PMID: 38678275 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- N01-HC-95162/HC/NHLBI NIH HHS/United States
- N01-HC-95159/HC/NHLBI NIH HHS/United States
- N01-HC-95165/HC/NHLBI NIH HHS/United States
- R01-HL 66075/HL/NHLBI NIH HHS/United States
- N01-HC-95164/HC/NHLBI NIH HHS/United States
- N01-HC-95160/HC/NHLBI NIH HHS/United States
- N01-HC-95166/HC/NHLBI NIH HHS/United States
- L30 HL129375/HL/NHLBI NIH HHS/United States
- N01-HC 9808/HC/NHLBI NIH HHS/United States
- N01-HC-95163/HC/NHLBI NIH HHS/United States
- N01-HC-95168/HC/NHLBI NIH HHS/United States
- N01-HC 95168/HC/NHLBI NIH HHS/United States
- N01-HC-95161/HC/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials